Welcome Guest
Home > Clinical Breast Cancer > Volume 6 | Supplement 2

Table of Contents

Volume 6 | Supplement 2

Publication Date: February 2006
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Contributions
Page Number of this Article in the Print Version
S36-S40		 Controversies in Adjuvant Endocrine Treatment of Premenopausal Women
Lori J. Goldstein
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S41-S44		 Exemestane as Adjuvant Treatment of Early Breast Cancer: Intergroup Exemestane Study/Tamoxifen Exemestane Adjuvant Multicenter Trials
Stephen E. Jones
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S45-S50		 Emerging Data on Optimal Adjuvant Endocrine Therapy: Breast International Group Trial 1-98/MA.17
Andrew M. Wardley
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S51-S57		 Current Status of Combined Hormone Replacement Therapy in Clinical Practice
Shona M. Tormey, Carmel M. Malone, Edna W. McDermott, Niall J. O’Higgins, Arnold D. K. Hill
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S58-S64		 Coronary Heart Disease and Stroke with Aromatase Inhibitor, Tamoxifen, and Menopausal Hormone Therapy Use
Rowan T. Chlebowski, Garnet L. Anderson, Michelle Geller, Nananda Col
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S65-S70		 Assessing Drug Risks and Benefits: Lessons from Postmenopausal Hormone Therapy Studies
Judith Hsia
  • Abstract
  • No Access
  • Add to Cart